PC
RMD icon

Polar Capital’s ResMed RMD Stock Holding History

Polar Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-110,000
Closed -$11.4M – 298
2019
Q1 		$11.4M Hold
110,000
– – 0.11% 178
2018
Q4 		$12.5M Buy
+110,000
New +$11.8M 0.13% 160
2018
Q2 		– Sell
-166,592
Closed -$16.4M – 267
2018
Q1 		$16.4M Buy
+166,592
New +$15.7M 0.17% 154

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital's RMD Position: Q2 2019 in Review

Polar Capital sold out of ResMed (RMD) in Q2 2019, closing a stake of 110,000 shares — an estimated $11.4M sold.

Polar Capital first reported a position in RMD in Q1 2018 and held it in 3 quarters. The position peaked at $16.4M in Q1 2018. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

  • Polar Capital reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
  • Polar Capital sold 110,000 ResMed shares in Q2 2019, an estimated $11.4M.
  • Polar Capital first reported a position in ResMed in Q1 2018 and held it in 3 quarters.
  • Polar Capital's ResMed position peaked at $16.4M in Q1 2018.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Polar Capital's 13F filing for Q2 2019, filed 14 Aug 2019.